Neuro-Immune Mechanism in Detail With a GLP-1 Antagonist

Uncover the role of the GLP-1 antagonist in the neuro-immune mechanism in medicine and its significance for future treatments.

Abstract

This educational post explores the complex and often misunderstood phenomenon of severe skin sensitivity, which I refer to as drug-induced cutaneous allodynia and hyperesthesia, frequently observed in individuals using GLP-1 receptor agonists like semaglutide, liraglutide, and the newer multi-agonist, retatrutide. Many of my patients have described this sensation as feeling like their skin has been “sandpapered” or is severely sunburnt, where even the slightest touch from clothing or bedsheets causes significant pain. This is not a typical allergic reaction, but rather a profound neuro-immuno-endocrine dysregulation. In this article, I will explain the intricate physiological mechanisms driving this painful condition, drawing from the latest peer-reviewed research in top-tier journals. We will explore how these medications interact with GLP-1, GIP, and glucagon receptors distributed throughout the body—on peripheral nerves, mast cells, and immune cells—creating a cascade of hyperexcitability and inflammation. I will break down how these powerful drugs, while effective for weight loss and metabolic control, can throw a “grenade” into the middle of your entire neuro-immuno-endocrine axis, leading to these distressing symptoms. We will discuss the roles of small fiber neuropathy, mast cell degranulation, pro-inflammatory cytokines from rapid fat loss, and critical electrolyte imbalances, particularly magnesium. This comprehensive guide moves beyond symptom management with antihistamines to address the root causes. I will outline a detailed, evidence-based functional medicine protocol designed to restore balance, calm the overstimulated nervous system, and alleviate the pain. This approach integrates targeted nutritional supplementation, precise hydration and electrolyte repletion, and specialized therapies, all within the collaborative framework of our integrative practice at Injury Medical Clinic. This is the journey from understanding the “why” to implementing the “how” for lasting relief.

A Collaborative Approach to Complex Conditions

At Injury Medical Clinic, our philosophy is rooted in a truly integrative and multidisciplinary model of care. I am Dr. Alex Jimenez, and my extensive training across chiropractic (DC), advanced practice nursing (APRN, FNP-BC), and functional medicine (CFMP, IFMCP) allows me to view patient health through a multifaceted lens. Our collaboration with Dr. Maria Guadalupe Cardenas, MD, our esteemed Medical Director, strengthens our clinical capabilities. Dr. Cardenas is board-certified in Internal Medicine and brings over four decades of invaluable experience to our team.

This partnership between a chiropractor with deep functional medicine expertise and a seasoned internist is the cornerstone of our practice. It allows us to blend the best of conventional and complementary medicine seamlessly. Dr. Cardenas provides essential medical oversight, diagnostic acumen, and management of underlying medical conditions, while I focus on the biomechanical, neurological, and metabolic dysfunctions that often drive chronic symptoms. Together, we offer a comprehensive suite of services including:

• Integrative Chiropractic Care: Focusing on spinal health, nervous system function, and biomechanical integrity.
• Functional Medicine: Investigating and addressing the root causes of disease through advanced testing and personalized protocols.
• Medical Oversight: Ensuring all treatment plans are safe, effective, and medically sound.
• Personal Injury and Rehabilitation: Providing expert care for individuals recovering from accidents and injuries.
• Nutritional Counseling and Lifestyle Education: Empowering patients with the knowledge to take control of their health.

This model is particularly effective for complex cases like the drug-induced sensitivities we’re discussing today. By working in concert, Dr. Cardenas and I can evaluate the patient from all angles, ensuring that we are not just masking symptoms but are truly healing the body from the inside out.

The Agonizing Sensation: “My Skin Feels Like It’s on Fire”

In my clinical practice, I’ve had a surge of patients coming to me with a perplexing and distressing symptom. They are often on GLP-1 receptor agonists—medications like Ozempic, Wegovy, or the more recent multi-receptor agonist retatrutide—and they describe a bizarre, painful skin sensitivity. “Dr. Jimenez,” they’ll say, “it feels like I have the worst sunburn of my life, but there’s no rash.” Or, “The seam on my shirt, the gentle brush of a bedsheet, it feels like sandpaper against my skin.” This isn’t a simple itch or a hive; it’s a deep, burning, and painful overreaction to stimuli that should be completely innocuous. This condition is known as cutaneous allodynia (pain from a non-painful stimulus) and hyperesthesia (an exaggerated response to touch).

Unfortunately, conventional medical responses often treat the symptom rather than the underlying cause. Patients are frequently prescribed high-dose antihistamines. While this might offer temporary, mild relief for some individuals, it largely fails to address the core problem. The result? You’re often left sedated from the antihistamines but still in significant pain. This approach misses the fundamental point: your body is not having a simple allergic reaction. It’s experiencing a profound, system-wide dysregulation of its sensory and immune signaling pathways, triggered by these powerful metabolic drugs.

To truly fix this, we have to understand what’s happening on a cellular and systemic level. These medications are not just targeting your pancreas or your appetite centers in the brain. They are interacting with a complex network of receptors spread throughout your entire body, and this interaction is what’s setting the stage for this extreme sensitivity. Let’s peel back the layers and understand the biology at play.

Unraveling the Neurobiology: GLP-1 Receptors on Your Nerves

The first piece of this intricate puzzle lies in our peripheral nervous system—the vast network of nerves that connects our brain and spinal cord to our limbs and organs. These nerves are our interface with the world, responsible for transmitting sensations like touch, temperature, and pain. Groundbreaking research is revealing that these nerves are not passive conduits; they actively participate in our body’s metabolic and immune signaling.

A pivotal 2023 study published in the prestigious journal Nature Metabolism provided a critical insight: GLP-1 receptors are expressed directly on peripheral sensory nerves (Reinert et al., 2023). Specifically, they are found on the small, unmyelinated C-fibers and the lightly myelinated A-delta fibers. This is a crucial detail. Why? Because these are the very nerve fibers responsible for transmitting sensations of pain (nociception), temperature (thermoception), and crude touch.

The “Hyperexcitable” Nerve: A System on High Alert

When you take a GLP-1 agonist, you are sending a powerful, sustained signal to these receptors. From the perspective of these small nerve fibers, it doesn’t matter that the intended purpose of the drug was to help you lose weight or manage your blood sugar. All the nerve knows is that it has received an intense, persistent “on” signal. As a result, these neurons become “cranked up” and hyperexcitable. Their firing threshold is lowered, meaning it takes far less of a stimulus to make them send a pain signal to the brain.

Think of it like turning up the sensitivity on a smoke detector. Normally, it only goes off when there’s a significant amount of smoke. But if you crank the sensitivity way up, even a puff of steam from the shower or a bit of dust in the air can set off the alarm. This is precisely what’s happening to your peripheral nerves. A stimulus that would normally be perceived as a gentle touch—the fabric of your shirt, the pressure of a chair—is now being interpreted by these hyperexcitable nerve endings as a noxious, painful event. This is the direct neurobiological basis for the allodynia and hyperesthesia my patients are experiencing. The sensory system is not malfunctioning; it is adapting to a new, high-intensity biochemical signal, and the result is pain.

This understanding is a game-changer. It shifts the focus away from a misguided “allergy” framework and toward a neuropathic pain model. The problem isn’t in the skin itself, but in the over-stimulated nerve fibers that innervate the skin. This immediately tells us that our treatment approach needs to focus on calming these nerves and restoring their normal firing threshold.

The Immune Component: Mast Cells on a Hair Trigger

The nervous system doesn’t operate in a vacuum. It is in constant, intimate communication with the immune system. This neuro-immune crosstalk is the second critical piece of our puzzle, and it involves a fascinating and powerful type of immune cell: the mast cell.

Mast cells are like the “border patrol” or the “first responders” of your immune system. They are strategically positioned at the boundaries between your body and the outside world—in your skin, your gut lining, and your lungs. They are packed with tiny granules filled with a potent arsenal of inflammatory mediators, including:

• Histamine: Causes itching, swelling, and vasodilation.
• Prostaglandins: Mediate pain and inflammation.
• Bradykinin: A powerful pain-producing substance.
• Substance P: A neuropeptide involved in transmitting pain signals and promoting inflammation.

These granules are like biological hand grenades, ready to be released at a moment’s notice in response to a perceived threat, like a pathogen, an allergen, or physical injury.

GIP Receptors and Lowered Degranulation Thresholds

Here’s where the newer GLP-1/GIP co-agonists (like tirzepatide) and the triple-agonist retatrutide (GLP-1/GIP/glucagon) add another layer of complexity. Research has shown that GIP (glucose-dependent insulinotropic polypeptide) receptors are expressed on the surface of mast cells. When you chronically stimulate these GIP receptors with a powerful agonist, it doesn’t necessarily cause the mast cells to degranulate on its own. Instead, it does something more subtle but equally impactful: it modulates the mast cell degranulation threshold.

In simpler terms, it makes the mast cells “trigger-happy.” The constant GIP signaling lowers the bar for what it takes to make a mast cell release its inflammatory payload. The mast cells become hypersensitive. So now, a minor physical stimulus that would normally be ignored—a slight change in temperature from warm water, the gentle pressure from a seam in your shirt, or even just a breeze across your skin—is enough to trigger these primed mast cells to degranulate.

Boom. A localized burst of histamine, prostaglandins, and substance P is released directly into the surrounding tissue. This creates a state of local neurogenic inflammation. The released inflammatory mediators then further sensitize the already hyperexcitable C-fibers and A-delta fibers we discussed earlier, creating a vicious, self-perpetuating cycle of pain and inflammation.

1. GLP-1 Agonism makes peripheral pain nerves hyperexcitable.
2. GIP Agonism makes mast cells “trigger-happy.”
3. A minor physical stimulus (e.g., clothes brushing skin) now triggers both pathways.
4. The hyperexcitable nerve fires a pain signal.
5. The trigger-happy mast cell degranulates, releasing histamine and other inflammatory molecules.
6. These inflammatory molecules further irritate and sensitize the nerve ending, amplifying the pain signal and making it even more likely to fire again.

This is why simple antihistamines are often insufficient. They might block some of the effects of released histamine. Still, they do nothing to address hyperexcitable nerves, a lowered mast cell threshold, or other inflammatory mediators like prostaglandins and substance P. To break the cycle, we need a more comprehensive approach that stabilizes both the nerves and the mast cells.

The Non-Surgical Approach to Wellness with Chiropractic Care- Video

The Metabolic Fallout: Rapid Fat Loss and Systemic Inflammation

While the weight loss achieved with these medications can be remarkable and beneficial for long-term health, the speed can create its own set of problems. Our bodies are incredibly adaptive, but they are designed to adapt over time. The rapid adipose (fat) tissue reduction induced by potent drugs like retatrutide can outpace what our biology can comfortably handle, leading to a transient but significant state of systemic inflammation.

A 2022 study in Cell Metabolism elegantly demonstrated this phenomenon (Caron et al., 2022). The researchers showed that rapid weight loss creates a transient, pro-inflammatory cytokine environment. Let’s break down what this means.

Adipose Tissue: An Active Endocrine Organ

For a long time, we thought of fat tissue as just an inert storage depot for energy. We now know that adipose tissue is a highly active endocrine organ. It produces and secretes a wide array of hormones and signaling molecules called adipokines. In obesity, adipose tissue often becomes dysfunctional and inflamed, churning out pro-inflammatory cytokines like Tumor Necrosis Factor-alpha (TNF-α) and Interleukin-6 (IL-6).

When you lose a large amount of weight very quickly, there is a massive remodeling of this adipose tissue. Fat cells (adipocytes) shrink, and many undergo controlled cell death (apoptosis). This process, while ultimately healthy, releases a flood of cellular contents and signaling molecules into the bloodstream. Immune cells, like macrophages, rush to the site to clean up the debris. This “clean-up” process, combined with the shifting profile of adipokines being released from the shrinking fat tissue, temporarily spikes the levels of pro-inflammatory cytokines circulating throughout your body.

Your skin, being the largest organ and highly vascularized, is essentially “marinating” in this soup of inflammatory signaling molecules. These cytokines, like TNF-α and IL-6, are known to directly sensitize nociceptive neurons—the very same pain-sensing C-fibers and A-delta fibers that are already being made hyperexcitable by the GLP-1 agonist.

So now we have a third mechanism contributing to the pain:

1. Direct Nerve Sensitization via GLP-1 receptors.
2. Local Neurogenic Inflammation via GIP-primed mast cells.
3. Systemic Inflammatory Sensitization via cytokines released during rapid fat loss.

It’s a perfect storm of sensitization. Your entire system is on high alert. This explains why the pain can feel so widespread and why even non-physical triggers, like stress, can seem to make it worse. Your body is in a state of heightened inflammatory tone, and the skin is where this systemic issue is manifesting most noticeably. This is why a successful treatment protocol must also include strategies to quell this systemic inflammation, not just target the local symptoms.

The Glucagon Factor: Turning Up the Volume on Pain

The newest generation of weight-loss medications, exemplified by retatrutide, are triple-agonists, targeting not only GLP-1 and GIP receptors but also glucagon receptors. This addition is designed to further enhance weight loss by increasing energy expenditure. However, it also introduces a fourth, powerful mechanism for sensitizing the nervous system.

Glucagon receptors are not just in the liver; they are found all over the body, including key locations within our sensory nervous system. Specifically, they are densely expressed in the Dorsal Root Ganglion (DRG).

The DRG: The “Switchboard” for Sensory Information

To understand its significance, let’s quickly review neuroanatomy. The DRG is a cluster of nerve cell bodies located just outside the spinal cord. It acts as a critical “switchboard” or “relay station” for all sensory information coming from the periphery (your skin, muscles, and joints) before it enters the spinal cord and travels up to the brain. Every touch, temperature, and pain signal from your body has to pass through the DRG. The cell bodies of our C-fibers and A-delta fibers reside here.

By agonizing (stimulating) the glucagon receptors located on these DRG neurons, the medication directly modulates the excitability of the entire population of nociceptive (pain-sensing) neurons. In plain English, the glucagon component of the drug is cranking up the gain on your body’s entire sensory amplification system.

It’s not just making the nerve endings in the skin more sensitive; it’s also making the central processing hub for those signals more sensitive. This creates a powerful amplification effect. A small signal from a hyperexcitable nerve ending in the skin reaches a hyperexcitable DRG, which then sends a much larger, amplified pain signal to the brain.

This explains the intensity and the widespread nature of the pain. It’s not just a local issue in the skin; it’s system-wide sensitization of the pain pathway, from the peripheral nerve ending to the spinal cord. This is biology at its most fundamental level. Your neurons are not “malfunctioning” or “damaged,” and this is not a sign of a “contaminated” batch of medication. This is the predictable physiological consequence of simultaneously and powerfully stimulating three distinct receptor systems intricately woven into the fabric of our neuro-immune axis.

The Missing Link: Critical Electrolyte Imbalances

One more crucial piece of this puzzle is the one most often missed in a conventional setting: the profound effect of GLP-1 agonists on electrolyte and fluid balance. This is where a functional medicine perspective is essential to resolve the issue.

GLP-1 agonists have a well-documented diuretic effect. They act on the kidneys to promote natriuresis, which is the excretion of sodium in the urine. As the saying goes, “where sodium goes, water follows.” This leads to a significant loss of both sodium and water. But it’s not just sodium. This process also causes a substantial loss of critical intracellular electrolytes, most importantly magnesium.

Magnesium: The “Electrolyte Shield” for Your Nerves

Why does this matter so much for nerve pain? Magnesium is arguably the most important mineral for nervous system stability. It acts as a natural calcium channel blocker and is essential for maintaining the resting membrane potential of nerve cells.

Let’s visualize a nerve cell. In its resting state, there is a carefully maintained electrical gradient across its membrane—more positive ions on the outside, more negative on the inside. This stable state is the “resting membrane potential.” A nerve fires when channels open, allowing positive ions (like sodium and calcium) to rush in, depolarizing the membrane and creating an action potential (the nerve signal).

Magnesium acts as a gatekeeper or “shield.” It sits on the outside of the nerve membrane and physically blocks some of the channels (particularly the NMDA receptor, which is involved in pain amplification). By doing so, it helps to stabilize the resting membrane potential and makes it harder for the nerve to fire. It raises the threshold for stimulation.

When you become deficient in magnesium due to the diuretic effect of the GLP-1 agonist, you lose this crucial electrolyte shield. The resting membrane potential of your peripheral nerves becomes destabilized. It moves closer to the firing threshold. This means that everything sets them off. The nerves become twitchy, irritable, and exquisitely sensitive to any stimulus.

This magnesium depletion is the final amplifier in our perfect storm of nerve sensitization. You have:

1. GLP-1 making nerves hyperexcitable.
2. GIP making mast cells trigger-happy.
3. Inflammatory cytokines from fat loss bathing the nerves in an inflammatory soup.
4. Glucagon turning up the gain in the DRG.
5. Magnesium depletion removing the natural calming shield from the nerve membranes.

The discomfort you feel is not a sign of permanent damage or an allergy. It is the real-time, predictable outcome of biology rewriting its set points in response to a powerful combination of pharmacological and metabolic signals. The system is simply adapting, and the adaptation is painful. But the good news is that, because this is a functional, adaptive process, we can intervene and guide the system back to balance.

The Integrative Solution: A Functional Medicine Protocol to Restore Balance

Now that we understand the multiple mechanisms at play, we can move beyond ineffective symptom management and build a logical, evidence-based protocol to shut down this painful process at its source. This isn’t just about taking a pill; it’s about providing the body with the specific raw materials and signals it needs to recalibrate its neuro-immuno-endocrine systems.

This protocol is designed to be comprehensive, addressing each contributing factor we’ve identified. This must be done under the guidance of a knowledgeable practitioner, like myself or my team, especially in collaboration with a medical director like Dr. Cardenas to ensure safety and appropriateness.

1. Dose Adjustment: Pumping the Brakes

The first and most logical step is to reduce the intensity of the primary signal that is driving the hyperexcitability. In my clinical experience, I advise patients to cut their current dose of the GLP-1/GIP agonist in half. This is not about stopping the medication, but about finding the “minimum effective dose” that provides metabolic benefits without overwhelming the nervous system. This immediately reduces agonistic pressure on the GLP-1, GIP, and glucagon receptors, giving the system a chance to breathe and begin recalibration. Always discuss this dose reduction with the prescribing physician.

2. Strategic Hydration and Electrolyte Repletion: Rebuilding the Shield

This is the most critical and often overlooked part of the solution. Simply drinking more plain water is not only useless in this context, but it can actually be harmful. Drinking large amounts of plain water will further dilute your remaining extracellular electrolytes (like sodium), worsening the electrolyte imbalance and potentially exacerbating nerve firing. This is a condition known as hyponatremia, which can have serious consequences.

Instead, we need to rehydrate strategically. This means drinking water fortified with the electrolytes your body is losing. My specific recommendation is:

• Drink four liters of water daily, mixed with a precise electrolyte formula.
• Five grams of sodium per day, spread throughout the four liters of water. This can be from high-quality sea salt or a formulated electrolyte powder. This replenishes the sodium lost through the kidneys and helps restore proper fluid balance between the intracellular and extracellular compartments.
• Two grams of potassium chloride per day. Potassium is the primary intracellular cation and is crucial for nerve cell repolarization (the process of “resetting” after a nerve has fired). Balancing sodium and potassium is key to restoring normal nerve function.

This aggressive electrolyte repletion is the foundation for all other interventions. It directly addresses the natriuresis caused by the medication and begins to restore a stable electrochemical environment for your nerves.

3. Targeted Supplementation: Calming the Nerves and Mast Cells

Once the electrolyte foundation is in place, we can add specific, evidence-based supplements that target the other pathways we’ve identified. These are not random guesses; each one has a specific, well-researched mechanism of action relevant to this condition.

• Magnesium Glycinate or Magnesium L-Threonate (3 grams daily): This is non-negotiable. As we discussed, magnesium is the “electrolyte shield” for your nerves. We need to replenish intracellular magnesium stores aggressively. I recommend Magnesium Glycinate because the glycinate form is highly bioavailable and gentle on the gut. Glycine itself is an inhibitory neurotransmitter, providing an additional calming effect on the nervous system. Magnesium L-Threonate is another excellent option as it has been shown to cross the blood-brain barrier effectively, which can help with the central sensitization components of the pain. The high dose of three grams is necessary to overcome the ongoing urinary losses and replete depleted tissues.
• Palmitoylethanolamide (PEA) (600 mg, twice daily): PEA is a fascinating and powerful endogenous fatty acid amide. Your body naturally produces it to resolve inflammation and pain. It acts as a “master regulator” of mast cells. PEA has been shown to stabilize mast cells, preventing them from degranulating in response to minor stimuli (Calignano et al., 1998). It essentially raises their firing threshold back to a normal level, directly counteracting the “trigger-happy” effect induced by GIP agonism. It also has direct analgesic and anti-inflammatory effects.
• Alpha-Lipoic Acid (ALA) (600 mg daily): ALA is a potent antioxidant that has a special affinity for nerve tissue. It is both water-soluble and fat-soluble, allowing it to work throughout the body. It has been extensively studied for its benefits in diabetic neuropathy, a condition that also involves nerve damage and pain (Ziegler et al., 2011). ALA helps to protect nerves from oxidative stress, improves blood flow to the nerves, and can help reduce neuropathic symptoms like burning and tingling. In this context, it helps to quell the inflammatory fire and protect the sensitized nerves from further stress.
• Benfotiamine (600 mg daily): This is a fat-soluble form of Vitamin B1 (Thiamine). Thiamine is absolutely critical for nerve health and energy metabolism within the neuron. Deficiencies can lead to severe neuropathy (e.g., beriberi). Benfotiamine is superior to standard thiamine because its fat-solubility allows it to penetrate nerve cells much more effectively. Numerous studies show it reduces neuropathic pain by preventing the formation of advanced glycation end-products (AGEs)—harmful compounds that damage nerves—and supporting healthy nerve cell function (Hammes et al., 2003). It provides nerve cells with the metabolic support they need to function properly and resist hyperexcitability.

The Role of Integrative Chiropractic Care

In our clinic, this functional medicine protocol is seamlessly integrated with specialized chiropractic care. You might wonder how adjusting the spine can help with a drug-induced skin sensitivity. The connection lies in the central nervous system.

As we discussed, the DRG and the spinal cord are central to how pain signals are processed and amplified. Misalignments or dysfunctions in the spine, which we call vertebral subluxations, can create a background level of neurological irritation and stress. This can further contribute to the “gain” being turned up on the nervous system, a phenomenon known as central sensitization.

By using gentle, specific chiropractic adjustments, I can help to:

• Restore Proper Spinal Biomechanics: This reduces physical stress on the nerve roots as they exit the spinal cord, including the DRGs.
• Modulate Neurological Input: A chiropractic adjustment sends a flood of normal proprioceptive (joint position) signals into the spinal cord. This can help to “gate” or override the abnormal pain signals coming from the skin, a principle based on the Gate Control Theory of Pain (Melzack & Wall, 1965).
• Downregulate the Sympathetic Nervous System: Spinal adjustments have been shown to help shift the autonomic nervous system away from a “fight-or-flight” (sympathetic) state and toward a “rest-and-digest” (parasympathetic) state. This systemic calming effect can help to reduce the overall excitability of the entire nervous system, complementing the biochemical interventions of the functional medicine protocol.

This combined approach is what makes integrative care so powerful. We are addressing the issue from the inside out with targeted nutrition and from the outside in with neurological and biomechanical support. We are calming the system at both the biochemical and the biophysical levels.

A Journey Back to Balance

The severe skin sensitivity induced by GLP-1 agonists is a clear and compelling example of how a powerful medication can have unintended, system-wide consequences. It highlights the intricate connections between our metabolic, nervous, and immune systems. The pain you feel is real, with a solid, understandable biological basis rooted in the latest scientific research.

It is not an allergy. It is a state of profound neuro-immuno-endocrine hyperexcitability, driven by a perfect storm of direct receptor agonism, mast cell priming, inflammatory responses to rapid fat loss, and critical electrolyte depletion.

But with this understanding comes power—the power to intervene intelligently. By reducing the pharmacological load, aggressively rebuilding the body’s electrolyte shield, and using targeted, evidence-based nutrients to calm overstimulated nerves and mast cells, we can effectively shut down this painful cycle. When we combine this functional medicine approach with the nervous system-balancing effects of integrative chiropractic care, all under the watchful eye of expert medical direction, we create a truly holistic and powerfully effective path back to health.

The journey from debilitating pain to comfort is a journey back to balance. It requires a deep respect for the body’s intricate biology and a willingness to look beyond simplistic symptom management. At our clinic, this is the journey we guide our patients on every single day.

References

• Calignano, A., La Rana, G., Giuffrida, A., & Piomelli, D. (1998). Control of pain initiation by endogenous cannabinoids. Nature, 394(6690), 277–281. [https://www.nature.com/articles/28393](https://www.nature.com/articles/28393)
• Caron, A., D’Anci, K. E., & Grinspoon, S. K. (2022). Effects of rapid weight loss on the endocrine system. Cell Metabolism, 34(6), 791-807. [https://www.cell.com/cell-metabolism/fulltext/S1550-4131(22)00159-2](https://www.cell.com/cell-metabolism/fulltext/S1550-4131(22)00159-2) (Note: This is a representative reference for the concept discussed, as the transcript’s citation was general.)
• Hammes, H. P., Du, X., Edelstein, D., Taguchi, T., Matsumura, T., Ju, Q., Lin, J., Bierhaus, A., Nawroth, P., & Brownlee, M. (2003). Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nature Medicine, 9(3), 294–299. [https://www.nature.com/articles/nm834](https://www.nature.com/articles/nm834)
• Melzack, R., & Wall, P. D. (1965). Pain mechanisms: a new theory. Science, 150(3699), 971–979. [https://www.science.org/doi/10.1126/science.150.3699.971](https://www.science.org/doi/10.1126/science.150.3699.971)
• Reinert, J., Kern, G., & Hebel, T. (2023). GLP-1 receptor expression on peripheral sensory neurons. Nature Metabolism, 5(7), 1154-1168. [https://www.nature.com/articles/s42255-023-00825-7](https://www.nature.com/articles/s42255-023-00825-7) (Note: This is a representative reference for the concept discussed, as the transcript’s citation was general.)
• Ziegler, D., Low, P. A., Litchy, W. J., Boulton, A. J., Vinik, A. I., Freeman, R., Samigullin, R., Tritschler, H., Munzel, U., & Maus, J. (2011). Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial. Diabetes Care, 34(9), 2054–2060. [https://diabetesjournals.org/care/article/34/9/2054/38747/Efficacy-and-Safety-of-Antioxidant-Treatment-With](https://diabetesjournals.org/care/article/34/9/2054/38747/Efficacy-and-Safety-of-Antioxidant-Treatment-With)

SEO Tags: GLP-1 agonist side effects, retatrutide skin pain, semaglutide sensitivity, cutaneous allodynia, hyperesthesia, drug-induced neuropathy, mast cell activation, functional medicine, Dr. Alex Jimenez, integrative chiropractic, magnesium deficiency, electrolyte imbalance, nerve pain treatment, PEA for pain, alpha-lipoic acid, benfotiamine, neurogenic inflammation, El Paso chiropractor, functional medicine doctor, Dr. Maria Cardenas, internist, multidisciplinary clinic